- Home
- Publications
- Publication Search
- Publication Details
Title
The Role of DNA Methylation in Renal Cell Carcinoma
Authors
Keywords
-
Journal
Molecular Diagnosis & Therapy
Volume 22, Issue 4, Pages 431-442
Publisher
Springer Nature
Online
2018-05-19
DOI
10.1007/s40291-018-0337-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genomic classifications of renal cell carcinoma: a critical step towards the future application of personalized kidney cancer care with pan-omics precision
- (2018) James J Hsieh et al. JOURNAL OF PATHOLOGY
- The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma
- (2018) Christopher J. Ricketts et al. Cell Reports
- Loss of SETD2, but not H3K36me3, correlates with aggressive clinicopathological features of clear cell renal cell carcinoma patients
- (2017) Lei Liu et al. BioScience Trends
- Prognostic DNA methylation markers for renal cell carcinoma: a systematic review
- (2017) Sophie C Joosten et al. Epigenomics
- The SWI/SNF Protein PBRM1 Restrains VHL-Loss-Driven Clear Cell Renal Cell Carcinoma
- (2017) Amrita M. Nargund et al. Cell Reports
- Biomarkers of Renal Tumors: the Current State and Clinical Perspectives
- (2017) Marina O. Golovastova et al. Current Urology Reports
- Renal cell carcinoma
- (2017) James J. Hsieh et al. Nature Reviews Disease Primers
- Prognostic value of cross-omics screening for kidney clear cell renal cancer survival
- (2016) Slavica Dimitrieva et al. Biology Direct
- An integrative genomics approach for identifying novel functional consequences of PBRM1 truncated mutations in clear cell renal cell carcinoma (ccRCC)
- (2016) Yuanyuan Wang et al. BMC GENOMICS
- Targeting CDK4/6 in patients with cancer
- (2016) Erika Hamilton et al. CANCER TREATMENT REVIEWS
- The Clinicopathological Significance of Epigenetic Silencing of VHL Promoter and Renal Cell Carcinoma: A Meta-Analysis
- (2016) Lei Yang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- A Four-Gene Promoter Methylation Marker Panel Consisting of GREM1, NEURL, LAD1, and NEFH Predicts Survival of Clear Cell Renal Cell Cancer Patients
- (2016) Iris J.H. van Vlodrop et al. CLINICAL CANCER RESEARCH
- DNA Methylation Signature Reveals Cell Ontogeny of Renal Cell Carcinomas
- (2016) G. G. Malouf et al. CLINICAL CANCER RESEARCH
- Concentration and Methylation of Cell-Free DNA from Blood Plasma as Diagnostic Markers of Renal Cancer
- (2016) Inessa Skrypkina et al. DISEASE MARKERS
- Association between RASSF1A promoter methylation and renal cell cancer susceptibility: a meta-analysis
- (2016) Y.Q. Huang et al. GENETICS AND MOLECULAR RESEARCH
- Notch Pathway Is Activated via Genetic and Epigenetic Alterations and Is a Therapeutic Target in Clear Cell Renal Cancer
- (2016) Tushar D. Bhagat et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy
- (2016) Alain Ravaud et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma
- (2016) NEW ENGLAND JOURNAL OF MEDICINE
- Database Resources of the National Center for Biotechnology Information
- (2016) NUCLEIC ACIDS RESEARCH
- A Protective Role for Androgen Receptor in Clear Cell Renal Cell Carcinoma Based on Mining TCGA Data
- (2016) Hongjuan Zhao et al. PLoS One
- Tumor Specific Epigenetic Silencing of Corticotropin Releasing Hormone -Binding Protein in Renal Cell Carcinoma: Association of Hypermethylation and Metastasis
- (2016) Hossein Tezval et al. PLoS One
- Epigenetic activation of the drug transporter OCT2 sensitizes renal cell carcinoma to oxaliplatin
- (2016) Yanqing Liu et al. Science Translational Medicine
- The cancer-retina antigen recoverin as a potential biomarker for renal tumors
- (2016) Marina O. Golovastova et al. TUMOR BIOLOGY
- DNA methylation status defines clinicopathological parameters including survival for patients with clear cell renal cell carcinoma (ccRCC)
- (2016) Emma Andersson Evelönn et al. TUMOR BIOLOGY
- Improving needle biopsy accuracy in small renal mass using tumor-specific DNA methylation markers
- (2016) Sameer Chopra et al. Oncotarget
- Multilevel Genomics-Based Taxonomy of Renal Cell Carcinoma
- (2016) Fengju Chen et al. Cell Reports
- Aberrant Methylation of RASSF1A gene Contribute to the Risk of Renal Cell Carcinoma: a Meta-Analysis
- (2015) Gan-Shen Yu et al. Asian Pacific Journal of Cancer Prevention
- Improving cancer immunotherapy with DNA methyltransferase inhibitors
- (2015) Mohammad H. Saleh et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Loss of 5-hydroxymethylcytosine is linked to gene body hypermethylation in kidney cancer
- (2015) Ke Chen et al. CELL RESEARCH
- Genomic DNA Hypomethylation and Risk of Renal Cell Carcinoma: A Case-Control Study
- (2015) J. Mendoza- Perez et al. CLINICAL CANCER RESEARCH
- Promoter Methylation of CDO1 Identifies Clear-Cell Renal Cell Cancer Patients with Poor Survival Outcome
- (2015) I. A. G. Deckers et al. CLINICAL CANCER RESEARCH
- Alterations of the spindle checkpoint pathway in clinicopathologically aggressive CpG island methylator phenotype clear cell renal cell carcinomas
- (2015) Eri Arai et al. INTERNATIONAL JOURNAL OF CANCER
- Role of DNA methylation in renal cell carcinoma
- (2015) Niraj Shenoy et al. Journal of Hematology & Oncology
- Preoperatively Misclassified, Surgically Removed Benign Renal Masses: A Systematic Review of Surgical Series and United States Population Level Burden Estimate
- (2015) David C. Johnson et al. JOURNAL OF UROLOGY
- Alterations in enhancer of zeste homolog 2, matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression are associated with ex vivo and in vitro bone metastasis in renal cell carcinoma
- (2015) JIANG WANG et al. Molecular Medicine Reports
- Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
- (2015) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- A CpG-methylation-based assay to predict survival in clear cell renal cell carcinoma
- (2015) Jin-Huan Wei et al. Nature Communications
- Inactivation of bone morphogenetic protein 2 may predict clinical outcome and poor overall survival for renal cell carcinoma through epigenetic pathways
- (2015) Yozo Mitsui et al. Oncotarget
- Dynamic reprogramming of DNA methylation in SETD2-deregulated renal cell carcinoma
- (2015) Rochelle L. Tiedemann et al. Oncotarget
- Prognostication of patients with clear cell renal cell carcinomas based on quantification of DNA methylation levels of CpG island methylator phenotype marker genes
- (2014) Ying Tian et al. BMC CANCER
- DNA methylation profiling reveals novel diagnostic biomarkers in renal cell carcinoma
- (2014) Brittany N Lasseigne et al. BMC Medicine
- Kidney Cancer Is Characterized by Aberrant Methylation of Tissue-Specific Enhancers That Are Prognostic for Overall Survival
- (2014) C. Y. Hu et al. CLINICAL CANCER RESEARCH
- Discoveries, therapies and opportunities
- (2014) W. Marston Linehan et al. Nature Reviews Urology
- DNA Methylation Biomarkers Predict Progression-Free and Overall Survival of Metastatic Renal Cell Cancer (mRCC) Treated with Antiangiogenic Therapies
- (2014) Inga Peters et al. PLoS One
- Renal cell carcinoma
- (2014) E. Jonasch et al. BMJ-British Medical Journal
- Neurofilament Heavy polypeptideCpG island methylation associates with prognosis of renal cell carcinoma and prediction of antivascular endothelial growth factor therapy response
- (2014) Natalia Dubrowinskaja et al. Cancer Medicine
- Hereditary Kidney Cancer Syndromes
- (2013) Naomi B. Haas et al. ADVANCES IN CHRONIC KIDNEY DISEASE
- The Role of Aberrant VHL/HIF Pathway Elements in Predicting Clinical Outcome to Pazopanib Therapy in Patients with Metastatic Clear-Cell Renal Cell Carcinoma
- (2013) T. K. Choueiri et al. CLINICAL CANCER RESEARCH
- DNA methylation profiling distinguishes histological subtypes of renal cell carcinoma
- (2013) Amy A. Slater et al. Epigenetics
- Differential DNA methylation with age displays both common and dynamic features across human tissues that are influenced by CpG landscape
- (2013) Kenneth Day et al. GENOME BIOLOGY
- Single-CpG-resolution methylome analysis identifies clinicopathologically aggressive CpG island methylator phenotype clear cell renal cell carcinomas
- (2012) Eri Arai et al. CARCINOGENESIS
- DNA methylation biomarkers in cancer: progress towards clinical implementation
- (2012) Thomas Mikeska et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Inhibition of -KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors
- (2012) M. Xiao et al. GENES & DEVELOPMENT
- Translational genomics: The challenge of developing cancer biomarkers
- (2012) J. D. Brooks GENOME RESEARCH
- State of the Science: An Update on Renal Cell Carcinoma
- (2012) E. Jonasch et al. MOLECULAR CANCER RESEARCH
- Understanding the language of Lys36 methylation at histone H3
- (2012) Eric J. Wagner et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- (2012) Marco Gerlinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Regulatory T-Cells and Associated Pathways in Metastatic Renal Cell Carcinoma (mRCC) Patients Undergoing DC-Vaccination and Cytokine-Therapy
- (2012) Adrian Schwarzer et al. PLoS One
- Gene expression profiling of the synergy of 5-aza-2′-deoxycytidine and paclitaxel against renal cell carcinoma
- (2012) Tiandong Han et al. World Journal of Surgical Oncology
- Serum cell-free DNA in renal cell carcinoma
- (2011) Michela de Martino et al. CANCER
- 5-Aza-2′-deoxycytidine enhances susceptibility of renal cell carcinoma to paclitaxel by decreasing LEF1/phospho-β-catenin expression
- (2011) Donghao Shang et al. CANCER LETTERS
- Cancer epigenetics: linking basic biology to clinical medicine
- (2011) Hsing-Chen Tsai et al. CELL RESEARCH
- Rapid Synthesis of New DNMT Inhibitors Derivatives of Procainamide
- (2011) Ludovic Halby et al. CHEMBIOCHEM
- Imaging features, follow-up, and management of incidentally detected renal lesions
- (2011) A.J. Bradley et al. CLINICAL RADIOLOGY
- Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma
- (2011) Ignacio Varela et al. NATURE
- Hsa-miR-9 methylation status is associated with cancer development and metastatic recurrence in patients with clear cell renal cell carcinoma
- (2010) M A T Hildebrandt et al. ONCOGENE
- Quantitative DNA Methylation Analysis of FOXP3 as a New Method for Counting Regulatory T Cells in Peripheral Blood and Solid Tissue
- (2009) G. Wieczorek et al. CANCER RESEARCH
- Genome-wide DNA methylation profiles in precancerous conditions and cancers
- (2009) Yae Kanai CANCER SCIENCE
- Epigenetics in cancer
- (2009) S. Sharma et al. CARCINOGENESIS
- CpG methylation profiling in VHL related and VHL unrelated renal cell carcinoma
- (2009) Fiona E McRonald et al. Molecular Cancer
- The VHL tumor suppressor and HIF: insights from genetic studies in mice
- (2008) P P Kapitsinou et al. CELL DEATH AND DIFFERENTIATION
- Genetic Clustering of Clear Cell Renal Cell Carcinoma Based on Array-Comparative Genomic Hybridization: Its Association with DNA Methylation Alteration and Patient Outcome
- (2008) E. Arai et al. CLINICAL CANCER RESEARCH
- Management of the Incidental Renal Mass
- (2008) Stuart G. Silverman et al. RADIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation